Abstract

Stepan will report Q2 results on July 29, 2026 Pre-Mkt; this preview outlines consensus expectations for revenue, margins and EPS, recaps last quarter’s performance, highlights the current quarter’s operational drivers, and synthesizes prevailing analyst opinions since January 1, 2026.

Market Forecast

Based on the company’s latest projections framework and market tracking, Stepan’s current-quarter revenue is forecast at 635.85 million US dollars, implying 6.29% year-over-year growth; forecast EBIT is 25.50 million US dollars with a 23.88% year-over-year decline, and forecast EPS is 0.61 with a 32.22% year-over-year decline. The prior report implied emphasis on stabilizing gross profit via pricing/mix and feedstock cost normalization; however, near-term net margin is still expected to lag last year, and adjusted EPS faces YoY pressure despite modest revenue growth. Operationally, management continues to stress a return to normalized volumes in everyday surfactants, gradual recovery in polymers downstream of construction markets, and steady specialty products demand. The most promising segment remains Surfactants, projected at approximately 453.69 million US dollars last quarter size, where improved customer offtake and mix upgrades could deliver outperformance even if pricing remains selective.

Last Quarter Review

In the previous quarter, Stepan delivered revenue of 604.51 million US dollars, a gross profit margin of 10.73%, GAAP net profit attributable to shareholders of -41.41 million US dollars and a net profit margin of -6.85%, with adjusted EPS of 0.45; revenue grew 1.90% year over year while EPS declined 46.43% year over year. A notable item was the deterioration in bottom-line performance relative to revenue growth, indicating compression from input-cost lags, inventory and plant-level inefficiencies, or mix headwinds. By business, Surfactants generated 453.69 million US dollars, Polymers 130.03 million US dollars, and Specialties 20.79 million US dollars, with Surfactants representing roughly three-quarters of the portfolio and continuing to anchor cash generation even during margin pressure.

Current Quarter Outlook

Main business: Surfactants

Surfactants remains the core driver this quarter, representing approximately three-quarters of consolidated sales last quarter. Demand indicators suggest continued normalization in home and personal care, with institutional and industrial channels mixed but showing pockets of restocking. The key swing factor is the spread between selling prices and feedstock costs; if raw materials remain stable, sequential gross margin could lift from the depressed prior-quarter level. Volume recovery in consumer end-markets supports throughput utilization, lowering unit costs, while customer mix upgrades in higher-value formulations can add incremental basis points to margin. The forecast profile implies modest top-line growth but cautious profitability, so investors should monitor whether contracting activity in North America and Latin America supports sequential improvement. Any improvement in contract pass-through timing would help restore some of the margin lost in the last quarter’s lag.

Most promising business: Polymers

Polymers, at roughly 130.03 million US dollars last quarter, is positioned for gradual improvement as downstream construction and insulation-related activity stabilizes. The year-over-year decline in EBIT and EPS guidance for the company underscores that recovery is not linear, yet the segment’s longer-cycle demand tied to rigid foam insulation and specialty polyols can provide margin leverage as volumes normalize. If construction activity improves seasonally and channel inventories remain lean, the business could benefit from better plant utilization and improved fixed-cost absorption. Pricing discipline and product mix toward higher-performance polyols are focal points; even modest volume gains can translate to outsized EBIT improvement given last quarter’s low base.

Key stock-price drivers this quarter

The first determinant is whether gross margin rebounds from 10.73% as raw material costs stabilize and pricing/mix actions carry through; a sequential margin lift would offset the forecast YoY EPS decline. The second is the trajectory of net margin, which was negative last quarter; investors will look for evidence of expense control and lower manufacturing variances to bring net margin closer to breakeven or positive territory. The third driver is the cadence of volumes across core consumer and construction end-markets: confirmation of restocking or demand stabilization could validate the revenue growth forecast of 6.29% and support a better earnings power exit rate into the second half. Lastly, any color on inventory normalization and order cadence from large detergent and insulation customers will be key for assessing sustainability.

Analyst Opinions

Across the collected views and rating updates in 2026, the majority stance is cautiously bullish. A noted example is Seaport Research, where analyst Michael Harrison upgraded Stepan to Buy with a 75.00 US dollars target, citing a setup for recovery as demand normalizes and operating execution improves. The upgrade aligns with a view that upside could emerge if gross margin lifts sequentially, given operating leverage in both Surfactants and Polymers. The bullish case emphasizes that revenue growth of 6.29% year over year alongside operational normalization can help narrow the gap to long-term profitability metrics; improvements in working capital discipline and plant efficiency are seen as tangible catalysts. While there are still concerns about year-over-year EPS pressure, the prevailing perspective is that sequential progress in margin and volumes will matter more for valuation in the near term, particularly if commentary confirms stable feedstocks and healthier order patterns.